128 related articles for article (PubMed ID: 34695559)
1. Characteristics of immune checkpoint regulators and potential role of soluble TIM-3 and LAG-3 in male patients with alcohol-associated liver disease.
Fadriquela A; Kim CS; Lee KJ; Kang SH; Lee JH
Alcohol; 2022 Feb; 98():9-17. PubMed ID: 34695559
[TBL] [Abstract][Full Text] [Related]
2. Roles and correlations of TIM-3 and LAG-3 with cytokines and chemokines in alcoholic liver disease.
Fadriquela A; Kim CS; Lee JH
Clin Chim Acta; 2023 Feb; 541():117248. PubMed ID: 36764507
[TBL] [Abstract][Full Text] [Related]
3. Soluble type immune checkpoint regulators using multiplex luminex immunoassay in chronic hepatitis B patients.
Fadriquela A; Kim CS; Lee KJ; Kang SH; Kim MY; Lee JH
J Clin Pathol; 2021 Dec; 74(12):780-786. PubMed ID: 34016716
[TBL] [Abstract][Full Text] [Related]
4. A comprehensive profiling of soluble immune checkpoints from the sera of patients with non-small cell lung cancer.
Peng Y; Zhang C; Rui Z; Tang W; Xu Y; Tao X; Zhao Q; Tong X
J Clin Lab Anal; 2022 Feb; 36(2):e24224. PubMed ID: 35019173
[TBL] [Abstract][Full Text] [Related]
5. Prognostic impacts of soluble immune checkpoint regulators and cytokines in patients with SARS-CoV-2 infection.
Lee N; Jeong S; Jeon K; Park MJ; Song W
Front Immunol; 2022; 13():903419. PubMed ID: 36045684
[TBL] [Abstract][Full Text] [Related]
6. Immune Checkpoint Axes Are Dysregulated in Patients With Alcoholic Hepatitis.
Li W; Xia Y; Yang J; Guo H; Sun G; Sanyal AJ; Shah VH; Lou Y; Zheng X; Chalasani N; Yu Q
Hepatol Commun; 2020 Apr; 4(4):588-605. PubMed ID: 32258953
[TBL] [Abstract][Full Text] [Related]
7. Characterization of multiple soluble immune checkpoints in individuals with different Mycobacterium tuberculosis infection status and dynamic changes during anti-tuberculosis treatment.
Chen H; Zhou J; Zhao X; Liu Q; Shao L; Zhu Y; Ou Q
BMC Infect Dis; 2022 Jun; 22(1):543. PubMed ID: 35701741
[TBL] [Abstract][Full Text] [Related]
8. Immune Co-inhibitory Receptors PD-1, CTLA-4, TIM-3, LAG-3, and TIGIT in Medullary Thyroid Cancers: A Large Cohort Study.
Shi X; Li CW; Tan LC; Wen SS; Liao T; Zhang Y; Chen TZ; Ma B; Yu PC; Lu ZW; Qu N; Wang Y; Shi RL; Wang YL; Ji QH; Wei WJ
J Clin Endocrinol Metab; 2021 Jan; 106(1):120-132. PubMed ID: 33000173
[TBL] [Abstract][Full Text] [Related]
9. Relationship between immune checkpoint proteins, tumour microenvironment characteristics, and prognosis in primary operable colorectal cancer.
Al-Badran SS; Grant L; Campo MV; Inthagard J; Pennel K; Quinn J; Konanahalli P; Hayman L; Horgan PG; McMillan DC; Roxburgh CS; Roseweir A; Park JH; Edwards J
J Pathol Clin Res; 2021 Mar; 7(2):121-134. PubMed ID: 33338327
[TBL] [Abstract][Full Text] [Related]
10. Soluble immune checkpoint molecules in patients with antineutrophil cytoplasmic antibody-associated vasculitis.
Pyo JY; Yoon T; Ahn SS; Song JJ; Park YB; Lee SW
Sci Rep; 2022 Dec; 12(1):21319. PubMed ID: 36494415
[TBL] [Abstract][Full Text] [Related]
11. Analysis of Co-inhibitory Receptor Expression in COVID-19 Infection Compared to Acute
Herrmann M; Schulte S; Wildner NH; Wittner M; Brehm TT; Ramharter M; Woost R; Lohse AW; Jacobs T; Schulze Zur Wiesch J
Front Immunol; 2020; 11():1870. PubMed ID: 32983106
[TBL] [Abstract][Full Text] [Related]
12. Expression Analysis and Significance of PD-1, LAG-3, and TIM-3 in Human Non-Small Cell Lung Cancer Using Spatially Resolved and Multiparametric Single-Cell Analysis.
Datar I; Sanmamed MF; Wang J; Henick BS; Choi J; Badri T; Dong W; Mani N; Toki M; Mejías LD; Lozano MD; Perez-Gracia JL; Velcheti V; Hellmann MD; Gainor JF; McEachern K; Jenkins D; Syrigos K; Politi K; Gettinger S; Rimm DL; Herbst RS; Melero I; Chen L; Schalper KA
Clin Cancer Res; 2019 Aug; 25(15):4663-4673. PubMed ID: 31053602
[TBL] [Abstract][Full Text] [Related]
13. Soluble T cell immunoglobulin mucin domain 3 is shed from CD8+ T cells by the sheddase ADAM10, is increased in plasma during untreated HIV infection, and correlates with HIV disease progression.
Clayton KL; Douglas-Vail MB; Nur-ur Rahman AK; Medcalf KE; Xie IY; Chew GM; Tandon R; Lanteri MC; Norris PJ; Deeks SG; Ndhlovu LC; Ostrowski MA
J Virol; 2015 Apr; 89(7):3723-36. PubMed ID: 25609823
[TBL] [Abstract][Full Text] [Related]
14. Assessment of the expression of the immune checkpoint molecules PD-1, CTLA4, TIM-3 and LAG-3 across different cancers in relation to treatment response, tumor-infiltrating immune cells and survival.
Tu L; Guan R; Yang H; Zhou Y; Hong W; Ma L; Zhao G; Yu M
Int J Cancer; 2020 Jul; 147(2):423-439. PubMed ID: 31721169
[TBL] [Abstract][Full Text] [Related]
15. Direct-acting antiviral treatment downregulates immune checkpoint inhibitor expression in patients with chronic hepatitis C.
Szereday L; Meggyes M; Berki T; Miseta A; Farkas N; Gervain J; Par A; Par G
Clin Exp Med; 2020 May; 20(2):219-230. PubMed ID: 32108916
[TBL] [Abstract][Full Text] [Related]
16. Elevated serum levels of checkpoint molecules in patients with adult Still's disease.
Fujita Y; Asano T; Matsumoto H; Matsuoka N; Temmoku J; Sato S; Furuya MY; Suzuki E; Watanabe H; Koga T; Kawakami A; Migita K
Arthritis Res Ther; 2020 Jul; 22(1):174. PubMed ID: 32698838
[TBL] [Abstract][Full Text] [Related]
17. Duodenal CD8+ T resident memory cell apoptosis contributes to gut barrier dysfunction and microbial translocation in early alcohol-associated liver disease in humans.
Maccioni L; Loriot A; Dewulf J; Bommer G; Horsmans Y; Lanthier N; Leclercq I; Schnabl B; Stärkel P
Aliment Pharmacol Ther; 2022 Sep; 56(6):1055-1070. PubMed ID: 35919965
[TBL] [Abstract][Full Text] [Related]
18. Soluble TIM3 and Its Ligands Galectin-9 and CEACAM1 Are in Disequilibrium During Alcohol-Related Liver Disease and Promote Impairment of Anti-bacterial Immunity.
Riva A; Palma E; Devshi D; Corrigall D; Adams H; Heaton N; Menon K; Preziosi M; Zamalloa A; Miquel R; Ryan JM; Wright G; Fairclough S; Evans A; Shawcross D; Schierwagen R; Klein S; Uschner FE; Praktiknjo M; Katzarov K; Hadzhiolova T; Pavlova S; Simonova M; Trebicka J; Williams R; Chokshi S
Front Physiol; 2021; 12():632502. PubMed ID: 33776793
[TBL] [Abstract][Full Text] [Related]
19. Assessment of the expression and response of PD-1, LAG-3, and TIM-3 after neoadjuvant radiotherapy in rectal cancer.
Peng QQ; Li JL; Xin PL; Du KX; Lin XY; Wu JX; Zhang MT; Kong XQ
Neoplasma; 2021 Jul; 68(4):742-750. PubMed ID: 33847134
[TBL] [Abstract][Full Text] [Related]
20. Exhaustion of Activated CD8 T Cells Predicts Disease Progression in Primary HIV-1 Infection.
Hoffmann M; Pantazis N; Martin GE; Hickling S; Hurst J; Meyerowitz J; Willberg CB; Robinson N; Brown H; Fisher M; Kinloch S; Babiker A; Weber J; Nwokolo N; Fox J; Fidler S; Phillips R; Frater J;
PLoS Pathog; 2016 Jul; 12(7):e1005661. PubMed ID: 27415828
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
